fashion -WSS

fashion

author：Wikipedia 2025-09-07 14:12:03 - browse：57712

Monica Bertagnolli -- Health Policy coverage from STAT — Dr. Monica Bertagnolli speaks during a visit from first lady Jill Biden to the University of California San Francisco Helen Diller Family Comprehensive Cancer Center in San Francisco, Friday, Oct. 7, 2022. (AP Photo/Jeff Chiu, Pool) Jeff Chiu/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will hold a confirmation hearing next month for Monica Bertagnolli, President Biden’s nominee to run the National Institutes of Health, he said Friday.

Sanders, whose health committee oversees the confirmation of the NIH nominee, had refused to hold a hearing on Bertagnolli until the Biden administration promised more drug pricing reform.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care.

Please enter a valid email address. Privacy Policy

HHS announced Friday a deal with Regeneron on the development of the Covid-19 monoclonal antibody. That deal seems to have satisfied Sanders’ demands, though Sanders said the administration must add reasonable pricing provisions to all drugs developed with the help of government funding.

“I welcome the Biden Administration’s announcement today that if Regeneron, through a $326 million contract recently signed with HHS, successfully develops a next generation monoclonal antibody for Covid-19 prevention, the list price of this drug must be equal to or lower than the price in other major countries,” Sanders said in a release.

Sen. Elizabeth Warren (D-Mass.) also had withheld support for Bertagnolli’s nomination until Bertagnolli agreed to Warren’s ethics demands. Bertagnolli agreed to not join the pharmaceutical industry or accept payment from the drug industry, until at least four years after leaving her government position.

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Alabama hospital puts IVF treatments on hold

WSS

Information blocking fines are now fair game in health care

Free Covid tests will again be offered to all U.S. households

Patients, doctors press FTC to beef up hospital merger scrutiny

Alabama IVF ruling threatens families facing fatal genetic disease

He's a Nobel laureate. Critics say he was misleading on Covid

Assistant physicians can help address the primary care shortage

knowledge

fashion

Sign up for D.C. Diagnosis

explore

New air purifier tech could be key to improving indoor air quality

Assistant physicians can help address the primary care shortage

Wildfire smoke exposes gaps in outdoor worker protections

STAT readers on older presidents, polypills, Medicare, and more

Affirmative action in medical school literally saved lives

Chamber of Commerce, DOJ clash in court over drug prices

DIEP, the 'gold standard' of breast reconstruction, is under threat

Antivenom research: Lessons from HIV applied in search for universal antidote

The high cost of giving birth even with insurance

People with substance use disorder deserve online privacy

hotspot

He's a Nobel laureate. Critics say he was misleading on Covid

PBMs drew scrutiny in House hearing — and so did pharma

House panel takes first step toward fixing drug shortages

The unintended consequences of overturning Roe v. Wade

Community Health Systems hospitals under DOJ investigation

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

leisure time

focus

focus

entertainment